Phenex Pharma

Developer of small molecules targeting nuclear receptors for the treatment of liver diseases & autoimmune diseases

placeLudwigshafen, Rhineland Palatinate, Germany calendar_todayFounded 2002 groups21 employees language phenex-pharma.com

Registered entities

Investor mix

7 investors on record; lead investors include Creathor Venture, LBBW Venture Capital; 1 has since exited.

Investor typeCountShare
Venture capital343%
Private equity114%
Other / undisclosed343%
Coming soon